Literature DB >> 29357792

Nonviral Delivery Systems for Cancer Gene Therapy: Strategies and Challenges.

Gayong Shim1, Dongyoon Kim1, Quoc-Viet Le1, Gyu Thae Park1, Taekhyun Kwon1, Yu-Kyoung Oh1.   

Abstract

Gene therapy has been receiving widespread attention due to its unique advantage in regulating the expression of specific target genes. In the field of cancer gene therapy, modulation of gene expression has been shown to decrease oncogenic factors in cancer cells or increase immune responses against cancer. Due to the macromolecular size and highly negative physicochemical features of plasmid DNA, efficient delivery systems are an essential ingredient for successful gene therapy. To date, a variety of nanostructures and materials have been studied as nonviral gene delivery systems. In this review, we will cover nonviral delivery strategies for cancer gene therapy, with a focus on target cancer genes and delivery materials. Moreover, we will address current challenges and perspectives for nonviral delivery-based cancer gene therapeutics. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Cancer gene therapy; DNA; Macromolecular; Nonviral delivery; Nonviral gene therapy; Target cancer gene.

Mesh:

Year:  2018        PMID: 29357792     DOI: 10.2174/1566523218666180119121949

Source DB:  PubMed          Journal:  Curr Gene Ther        ISSN: 1566-5232            Impact factor:   4.391


  11 in total

1.  Resveratrol and siRNA in combination reduces Hsp27 expression and induces caspase-3 activity in human glioblastoma cells.

Authors:  Evren Önay Uçar; Aslıhan Şengelen
Journal:  Cell Stress Chaperones       Date:  2019-05-09       Impact factor: 3.667

2.  Recent Advances in Gene Therapy for Cancer Theranostics.

Authors:  Hannah J Vaughan; Jordan J Green
Journal:  Curr Opin Biomed Eng       Date:  2021-07-15

Review 3.  Nonviral Gene Therapy for Cancer: A Review.

Authors:  Chiaki Hidai; Hisataka Kitano
Journal:  Diseases       Date:  2018-07-03

4.  Intratumoral IL-12 Gene Therapy Inhibits Tumor Growth In A HCC-Hu-PBL-NOD/SCID Murine Model.

Authors:  Zhi-Feng Zhou; Feng Peng; Jie-Yu Li; Yun-Bin Ye
Journal:  Onco Targets Ther       Date:  2019-09-20       Impact factor: 4.147

5.  Improved gene delivery to K-562 leukemia cells by lipoic acid modified block copolymer micelles.

Authors:  Friederike Richter; Prosper Mapfumo; Liam Martin; Jana I Solomun; Franziska Hausig; Jochen J Frietsch; Thomas Ernst; Stephanie Hoeppener; Johannes C Brendel; Anja Traeger
Journal:  J Nanobiotechnology       Date:  2021-03-06       Impact factor: 10.435

6.  Cationic Single-Chained Surfactants with a Functional Group at the End of the Hydrophobic Tail DNA Compacting Efficiency.

Authors:  José Antonio Lebrón; Pilar López-Cornejo; Elena García-Dionisio; Pablo Huertas; Margarita García-Calderón; María Luisa Moyá; Francisco José Ostos; Manuel López-López
Journal:  Pharmaceutics       Date:  2021-04-20       Impact factor: 6.321

Review 7.  Applications and developments of gene therapy drug delivery systems for genetic diseases.

Authors:  Xiuhua Pan; Hanitrarimalala Veroniaina; Nan Su; Kang Sha; Fenglin Jiang; Zhenghong Wu; Xiaole Qi
Journal:  Asian J Pharm Sci       Date:  2021-06-27       Impact factor: 6.598

Review 8.  A Quality by Design Approach in Pharmaceutical Development of Non-Viral Vectors with a Focus on miRNA.

Authors:  Ioana Toma; Alina Silvia Porfire; Lucia Ruxandra Tefas; Ioana Berindan-Neagoe; Ioan Tomuță
Journal:  Pharmaceutics       Date:  2022-07-16       Impact factor: 6.525

Review 9.  Emerging and Innovative Theranostic Approaches for Mesoporous Silica Nanoparticles in Hepatocellular Carcinoma: Current Status and Advances.

Authors:  Yaoye Tao; Jianguo Wang; Xiao Xu
Journal:  Front Bioeng Biotechnol       Date:  2020-03-10

10.  High-throughput 5' UTR engineering for enhanced protein production in non-viral gene therapies.

Authors:  Jicong Cao; Eva Maria Novoa; Zhizhuo Zhang; William C W Chen; Dianbo Liu; Gigi C G Choi; Alan S L Wong; Claudia Wehrspaun; Manolis Kellis; Timothy K Lu
Journal:  Nat Commun       Date:  2021-07-06       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.